AMBRA1 and benign prostatic hyperplasia: It has been shown that the increased expression of AMBRA1 in PCa has a significant correlation with Gleason score, and the expression of AMBRA1 and SQSTM1 mRNA is significantly upregulated in PCa samples compared to benign prostatic hyperplasia, which may potentially contribute to PCa progression [42].